LH
Linda C. Hogan
Head, Bus. Dev. and Strategy

Linda C. Hogan insider trades: CoLucid Pharmaceuticals (CLCD) stock sales

Head, Bus. Dev. and Strategy, CoLucid Pharmaceuticals Last trade Jan 5, 2017 10 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2016
1
Company
last trade 2017

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Linda reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 5, 2017CLCD↓ Sell10b5-1$91K
Dec 5, 2016CLCD↓ Sell10b5-1$98K
Nov 7, 2016CLCD↓ Sell10b5-1$53K
Nov 1, 2016CLCD↓ Sell10b5-1$22K
Oct 5, 2016CLCD↓ Sell10b5-1$96K
Sep 6, 2016CLCD↓ Sell10b5-1$896K
Sep 6, 2016CLCD↓ Sell10b5-1$73K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Linda C. Hogan's insider trades

Linda C. Hogan is Head, Bus. Dev. and Strategy at CoLucid Pharmaceuticals (CLCD). Since Sep 6, 2016, Linda has reported no open-market purchases and 7 sales worth $1.3M on SEC Form 4. There have been no open-market trades in the last 12 months.

7 sales (100% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include option exercises (6 filings), grants and awards (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CLCD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.